BBOTVSEOCN• 7 Days (Normalized)
BBOT vs EOCN (BridgeBio Oncology Therapeutics Inc. vs Eocene Ltd.)
Showing Closing Date Range from Sep 30 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-14.63%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
EOCN Performance $3.36
-3.72%
Eocene Ltd.
Normalized Baseline0.00%
Alpha Spread Margin EOCN LEADS
-10.91 pts
EOCN outperforming by 10.91 percentage points
BBOTEOCN
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT EOCN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BBOT Price | BBOT Gain (%) | EOCN Price | EOCN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -14.63% | $3.36 | -3.72% | -10.91% |
| Oct 05, 2026 | $3.60 | -12.20% | $3.45 | -1.15% | -11.05% |
| Oct 02, 2026 | $3.89 | -5.12% | $3.61 | +3.44% | -8.56% |
| Oct 01, 2026 | $- | $3.41 | -2.44% | - | |
| Sep 30, 2026 | $4.10 | +0.00% | $3.49 | +0.00% | +0.00% |